Mydecine Unveils Four Psychedelic Drug Candidates

Mydecine Innovations Group (OTC: MYCOF), a Denver-based psychedelics research company, announced its four lead novel drug candidates on Wednesday.

The company plans to present the candidates at Pre-Investigational New Drug meetings with the FDA and Health Canada, a necessary step in obtaining approval for drug development and clinical trials.

“We are essentially taking the value that is currently present in natural molecules, such as the …

Full story available on Benzinga.com

More Mydecine Unveils Four Psychedelic Drug Candidates